Axogen, Inc. (AXGN)
Nasdaq: AXGN · Electromedical & Electrotherapeutic Apparatus · Alachua, FL · filing with the SEC since 1995
Who owns Axogen, Inc.
As filed with the SECHolders of 5% or more
2
Mathew P. Arens holds 7.58% of Common Stock, $0.01 par value, as its SCHEDULE 13G/A filed Aug 14, 2026 says.
Directors and officers
13
report now, of 36 people on the record since 2010. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 2 named at left.
Holders of 5% or moreshare of the class, as filed
Mathew P. Arens
SCHEDULE 13G/A · filed Aug 14, 2026 · Common Stock, $0.01 par value · 6.8% in May 7, 2026
Divisadero Street Capital Management, LP
SCHEDULE 13G · filed Oct 2, 2026 · Common Stock, $0.01 par value
Morgan Stanley
SCHEDULE 13G/A · filed Feb 3, 2025 · Common Stock · reported falling below 5%
Vanguard Capital Management
SCHEDULE 13G/A · filed Jul 31, 2026 · Common Stock · reported falling below 5%, from 5.12% in Apr 29, 2026
Soleus Capital Master Fund, L.P.
SCHEDULE 13G/A · filed May 2, 2025 · Common Stock, $0.01 par value per share · reported falling below 5%
ArrowMark Colorado Holdings, LLC
SCHEDULE 13G/A · filed May 15, 2025 · Common Stock, par value $0.01 per share · reported falling below 5%
The Vanguard Group
SCHEDULE 13G/A · filed Mar 26, 2026 · Common Stock · reported falling below 5%
What AXGN reports owning in othersstakes of 5% or more, and other ties
2 subsidiaries in 1 country, from the list filed with the 10-K filed Feb 24, 2026.
Insider tradesForm 4
47sales
0purchases
16sales on a scheduled plan
12people selling
$19.9Msold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window12 of 41 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Began Marc A | EVP & General Counsel | 3 | $3.9M | 1 | 0 | $0 |
| Burke William P. Mr. | director | 13 | $2.8M | 12 | 0 | $0 |
| Dale Michael D | Chief Executive Officer | 2 | $2.7M | 0 | 0 | $0 |
| Weiler Kathy Johnson | director | 5 | $2.7M | 1 | 0 | $0 |
| Wendell Amy Mcbride | director | 5 | $2.0M | 1 | 0 | $0 |
| Johnson John | director | 5 | $1.9M | 0 | 0 | $0 |
| Tyndall Joseph A. | director | 3 | $1.0M | 1 | 0 | $0 |
| Hartley Lindsey Marie | CFO | 5 | $900,000 | 0 | 0 | $0 |
| Devinney Erick Wayne | Chief Innovation Officer | 2 | $800,000 | 0 | 0 | $0 |
| Thomas Paul | director | 1 | $600,000 | 0 | 0 | $0 |
| Kemp Jens | Chief Marketing Officer | 2 | $400,000 | 0 | 0 | $0 |
| Quackenbush Doris | Sales VP | 1 | $200,000 | 0 | 0 | $0 |